Letters: New Observations
Medication costs following subthalamic nucleus deep brain stimulation for Parkinson's disease
Funding agencies: South-Eastern Norway Regional Health Authority
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
No abstract is available for this article.